SOD1 and amyotrophic lateral sclerosis: Furthermore, intracerebroventricular infusion and also intraperitoneal injections of α-miSOD1 antibody to transgenic mice expressing ALS-linked mutant human SOD1 (G37R and G93A) delayed the onset of motor symptoms and extended survival [71].